20045 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application; Pulmonary tract; Aromatherapy; Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS
#302NICOTINE DOSAGE REGIMEN
#303Compositions and methods for treating and preventing lung disease
#304Compositions and methods of making brittle-matrix particles through blister pack freezing
#305Methods and compositions for treating aging-associated impairments using CCR3-inhibitors
#306Procaspase combination therapy for glioblastoma
#307Procaspase 3 activation by combination therapy
#308Glucocorticoid combined with polyethylene glycol-modified interleukin 2 for treating respiratory disease
#309N4-hydroxycytidine and derivatives and anti-viral uses related thereto
#310COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#311Process and Method to Accelerate Cellular Regeneration, Healing and Wound Management
#312VAPOR MEDICINE DISPENSING AND NANO-MIST LUNG CLEANSER SYSTEM WITH FACE ADAPTER
#313FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION
#314Combination therapy for COPD
#315Compositions for respiratory delivery of active agents and associated methods and systems
#316Low dose therapeutic treatment
#317ACCESSORY DEVICE FOR METERED DOSE INHALER AND METHODS OF USE
#318Low-temperature inhalation administration of cannabinoid entities
#319Anti-infection and anti-tumor mucosal immune preparation
#320Biologic scaffold for prevention of pulmonary fibrosis
#321Cannabinoid formulations for inhalation
#322Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
#323Methods of treatment using a JAK inhibitor compound
#324Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
#325Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation
#326Formulations
#327PALONOSETRON FORMULATIONS AND USES THEREOF
#328PHARMACEUTICAL COMPOSITION
#329Metered dose inhaler compositions, systems, and methods
#330COMBINATION OF FUROSEMIDE AND STEROIDS AND USES THEREFOR
#331ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
#332LEVALBUTEROL SALT
#333Pressurized metered dose inhalers and method of manufacture
#334COMPOSITIONS AND METHODS FOR TREATING LUNG DISEASES AND LUNG INJURY
#335CROMOLYN COMPOSITIONS FOR TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONARY FIBROSIS
#336Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
#337Manufacture of pharmaceutical compositions
#338LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#339Ciclesonide for the treatment of airway disease in horses
#340COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING B2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS
#341FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION
#342Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
#343Combination therapy for COPD
#344AEROSOL FORMULATION FOR COPD
#345Unit aerosol doses for anticoagulation
#346COMPOSITION AND METHODS TO IMPROVE STABILITY, DOSING, PHARMACODYNAMICS AND PRODUCT SHELF LIFE OF ENDOCANNABINOIDS, PHYTOCANNABINOIDS AND SYNTHETIC CANNABINOIDS DELIVERED BY NASAL INHAER
#347Composition for inhalation
#348NOVEL PROPELLANT CONTAINING PREPARATIONS FOR TIOTROPIUM
#3493,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds
#350Method of preventing or treating a pulmonary disease or condition
#351NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#352NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF
#353Emulsions for intrapulmonary delivery
#354COMBINATIONS OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#355Pharmaceutical compositions
#356Peptide inhibition of CCR3-mediated diseases or conditions
#357METHOD OF FORMING CONCENTRATED SOLUTION
#358Taurine compositions suitable for inhalation
#359Formulations
#360PROCESS FOR IMPROVING CRYSTALLINITY
#361Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist
#362Method of making particles for use in a pharmaceutical composition
#363Inhalable formulation
#364COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS USING SAME
#3658'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS
#366Conformal coating of cells for immunoisolation
#367Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation
#368MDI related products and methods of use
#369High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
#370High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
#371ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
#372METHOD OF PREPARING A PHARMACEUTICAL COMPOSITION
#373DEVICE FOR INTRANASAL ADMINISTRATION
#374Particulate materials
#375Pharmaceutical compositions for inhalation
#376Compositions comprising salbutamol sulphate
#377INTRANASAL ADMINISTRATION OF KETAMINE TO TREAT DEPRESSION
#378Tannin-chitosan composites
#379COMBINATIONS OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#380Pharmaceutical Composition Comprising a Beta-2-Agonist and Anticholinergic Agent
#381COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND ASSOCIATED METHODS AND SYSTEMS
#382Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
#383Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#384Ciclesonide for the treatment of airway disease in horses
#385COMBINATION THERAPY FOR COPD
#386COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS
#387Pharmaceutical solution formulations for pressurised metered dose inhalers
#388Cannabinoid compositions and uses
#389COMPOSITIONS AND METHODS FOR THE TREATMENT OF SARCOIDOSIS
#390Procaspase combination therapy for glioblastoma
#391INHALABLE MEDICAMENT
#392Pharmaceutical compositions
#393Inhalable medicament comprising tiotropium
#394Pharmaceutical compositions
#395Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
#396COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
#397Pressurised metered dose inhalers and method of manufacture
#398Procaspase 3 activation by combination therapy
#399Pro-angiogenic peptides and peptide conjugates
#400Aerosol formulations of granisetron and uses thereof
#401Crystalline microparticles of a beta-agonist coated with a fatty acid
#402MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS
#403Aerosol formulations of ondansetron and uses thereof
#404Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#405Aerosol formulations comprising formoterol fumarate dihydrate
#406PHARMACEUTICAL COMPOSITIONS COMPRISING ARFORMOTEROL AND GLYCOPYRRONIUM
#407Recombinant lubricin composition
#408Stable pressurized aerosol solution composition of glycopyrronium bromide and formoterol combination
#409Stable pressurized aerosol solution composition of glycopyrronium bromide and formoterol combination
#410COMBINATIONS OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#411Particle size reduction of an antimuscarinic compound
#4128'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS
#413Control of rheological properties of mixed hyaluronate/lubricin solutions
#414AN INHALABLE MEDICAMENT
#415Quinine compounds, and optical isomers, preparation method and medical use thereof
#416Inhalable medicament
#417Method of making particles for use in a pharmaceutical composition
#418MEDICINAL AEROSOL FORMULATIONS
#419Methods and compositions for treating mucusal tissue disorders
#420Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis
#421INHALABLE MEDICAMENT
#422METHODS FOR TREATING AND/OR PREVENTING EMESIS AND/OR NAUSEA INCLUDING ACUTE AND/OR DELAYED NAUSEA AND/OR ACUTE EMESIS AND/OR DELAYED EMESIS
#423Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities
#424METHOD AND DEVICES FOR MANUFACTURING AND DELIVERING OF AEROSOLIZED FORMULATIONS
#425Treprostinil administration by inhalation
#426Trehalose and dextran-containing solution for transplanting mammalian cells
#427Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#428NOVEL PROPELLANT CONTAINING PREPARATIONS FOR TIOTROPIUM
#429PHARMACEUTICAL COMPOSITIONS
#430Inhalable Pharmaceutical Compositions and the Inhaler Devices Containing Them
#431Composition comprising salbutamol sulphate
#432TAURINE COMPOSITIONS SUITABLE FOR INHALATION
#433Nanoparticle drug delivery systems
#434Composition for Inhalation
#435Drug combination
#436Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions
#437Treatment of Smell and Taste Disorders Using Orally Administered Interferon-Alpha
#438Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist
#439Nicotine Dosage Regimen
#440Methods to treat inflammation of the lung
#441Pheromone compositions and their use to modify behavior in different vertebrate species
#442Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic
#443Multi-Component Crystalline Particles for Inhalation Therapy
#444Combination therapy for COPD
#445Enhanced delivery of drug compositions to treat life threatening infections
#446Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
#447Ciclesonide for the treatment of airway disease in horses
#448Aerosol formulation for COPD
#4493,5-diamino-6-chloro-N-(n-(4-phenylbutyl)carbamimidoyl)pyrazine-2-carboxamide compounds
#450Nicotine composition
#451Administration of aerosolised iloprost
#452Multifunctional radical quenchers
#453COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CHRONIC LUNG ALLOGRAFT DYSFUNCTION (CLAD) AND IDIOPATHIC PULMONARY FIBROSIS (IPF)
#454NOVEL PROPELLANT CONTAINING PREPARATIONS FOR TIOTROPIUM
#455Pharmaceutical Composition
#456METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN
#457ADMINISTRATION OF DIHYDROERGOTAMINE MESYLATE PARTICLES USING A METERED DOSE INHALER
#458Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#459Cannabinoid inhaler and composition therefor
#460Acetamide stereoisomer
#461Inhalable medicament
#462Stable pressurized aerosol solution composition of glycopyrronium bromide and formoterol combination
#463COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF THREE OR MORE ACTIVE AGENTS
#464Uses of antagonists of hyaluronan signaling
#465Potent anticancer activity via dual compound activation
#466Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids
#467Pharmaceutical compositions for inhalation
#468COMBINATIONS OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#469Pharmaceutical composition
#470Method of making particles for use in a pharmaceutical composition
#471LEVALBUTEROL SALT
#472Administration of benzodiazepine compositions
#473Procaspase combination therapy for glioblastoma
#474Method of Using Dihydroergotamine for Pre-emptive Treatment of Migraine
#475Procaspase 3 activation by combination therapy
#476COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING B2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS
#477Compositions, methods and systems for respiratory delivery of two or more active agents
#478Methods and compositions for treating mucosal tissue disorders
#479NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#480SUSTAINED-RELEASE FORMULATION OF ROTIGOTINE
#481COMPOSITIONS, METHODS AND SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
#482PULMONARY ADMINISTRATION OF ROTIGOTINE
#483Aerosols for sinunasal drug delivery
#484AEROSOL FORMULATION FOR COPD
#485Inhalable medicament comprising tiotropium
#486Particulate materials
#487Medicinal aerosols and methods of delivery thereof
#488Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis
#489Therapeutic methods and agents for treating myotonic dystrophy
#490COMPOSITION FOR INHALATION
#491Compositions comprising salbutamol sulphate
#492Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#493PHARMACEUTICAL COMPOSITIONS
#494Compositions comprising salbutamol sulphate
#495Pharmaceutical compositions
#496Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof
#497Phospholipid-based powders for drug delivery
#498FLUOROERGOLINE DERIVATIVES AND USES THEREOF
#499Pharmaceutical aerosol product for administration by oral or nasal inhalation
#500Conformal coating of cells for immunoisolation
#501Pharmaceutical composition
#502Tannin-chitosan composites
#503Saccharide conjugates
#504Combination vaccine
#505Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
#506Particulate materials
#507Compound composition for inhalation used for treating asthma
#508Inhalation devices and related methods for administration of sedative hypnotic compounds
#509Thioxothiazolidine inhibitors
#510Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
#511NOVEL PROPELLANT CONTAINING PREPARATIONS FOR TIOTROPIUM
#512Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
#513Levalbuterol salt
#514Stabilized Metered Dose Inhaler
#515Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
#516Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents
#517CRYSTALLINE MICROPARTICLES OF A BETA-AGONIST COATED WITH A FATTY ACID
#518Pheromone compositions and their use to modify behavior in different vertebrate species
#519Pheromone compositions and their use to modify behavior in different vertebrate species
#520Administration of benzodiazepine compositions
#521Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#522Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#523Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity
#524Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#525AEROSOLIZED NITRITE AND NITRIC OXIDE-DONATING COMPOUNDS AND USES THEREOF
#526LEVALBUTEROL SALT
#527Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof
#528Composition for nasal administration and method for preparing same
#529CERIA FOR USE AS AN ANTIMICROBIAL BARRIER AND DISINFECTANT IN A WOUND DRESSING
#530Stable liquid desoximethasone compositions with reduced oxidized impurity
#531PHARMACEUTICAL COMPOSITIONS COMPRISING 17ALPHA-FURANYLESTERS OF 17BETA-CARBOTHIATE ANDROSTANES WITH A MUSCARINIC RECEPTOR ANTAGONIST
#532Phospholipid-based inhalation system
#533Compositions for treating pseudomonas infection
#534Improved Medicinal Aerosol Formulations
#535Micelle encapsulation of therapeutic agents
#536FORMULATIONS AND METHODS FOR CONTROLLING MDI PARTICLE SIZE DELIVERY
#537Formulations
#538COMBINATION OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#539DRONABINOL TREATMENT FOR MIGRAINES
#540Delivery of submicrometer and nanometer aerosols to the lungs using hygroscopic excipients or dual stream nasal delivery
#541Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#542Composition for inhalation
#543Treprostinil administration by inhalation
#544DRY POWDER AEROSOLS OF NANOPARTICULATE DRUGS
#545Non-ozone depleting medicinal formulations with low greenhouse effect
#546Stable, non-corrosive formulations for pressurized metered dose inhalers
#547PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND CORTICOSTEROIDS
#548Pressurized Metered Dose Inhalers
#549Soft anticholinergic esters
#550Anhydrate of tiotropium bromide
#551Soft anticholinergic zwitterions
#552DRY POWDER COMPOSITION COMPRISING CO-JET MILLED PARTICLES FOR PULMONARY INHALATION
#553USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE
#554FORMULATIONS FOR USE IN INHALER DEVICES
#555METHOD OF TREATING REACTIVE AIRWAY DISEASE
#556INHALABLE AZTREONAM FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
#557Pulmonary Delivery in Treating Disorders of the Central Nervous System
#558USE OF R-BAMBUTEROL AS INHALED MEDICAMENT AND COMBINATION THERAPIES FOR TREATMENT OF RESPIRATORY DISORDERS
#559Combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
#560Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
#561METHODS FOR TREATING AND PREVENTING PNEUMONIA AND VENTILATOR-ASSOCIATED TRACHEOBRONCHITIS
#562Particulate materials
#563STABLE PHARMACEUTICAL DRUG PRODUCTS
#564Compositions, methods and systems for respiratory delivery of two or more active agents
#565Compositions, methods and systems for respiratory delivery of two or more active agents
#566Pharmaceutical formulation comprising a phosphodiesterase inhibitor
#567Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
#568CORTICOSTEROID COMPOSITIONS AND METHODS OF TREATMENTS THEREOF
#569Use of salt of an acetylsalicylic acid for the treatment of viral infections
#570Methods of using a thiazole derivative
#571TACROLIMUS COMPOSITIONS FOR AEROSOL ADMINISTRATION
#572Pyrazinopyrazines and derivatives as kinase inhibitors
#573METHOD TO GENERATE WATER SOLUBLE OR NONWATER SOLUBLE IN NANOPARTICULATES DIRECTLY IN SUSPENSION OF DISPERSION MEDIA
#574Biologic scaffold for prevention of pulmonary fibrosis
#575ARFORMOTEROL AND TIOTROPIUM COMPOSITIONS AND METHODS FOR USE
#576Compositions and Methods of Treating and Preventing Lung Cancer
#577PROPELLANT FOR DOSING AEROSOLS COMPRISING PACKAGINGS
#578INHALABLE PHARMACEUTICAL COMPOSITION
#579NAPADISYLATE SALT OF 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE BETA 2 ADRENERGIC RECEPTOR
#580Suspension formulations
#581INHALATION DRUG PRODUCTS, SYSTEMS AND USES
#582ADMINISTRATION OF DIHYDROERGOTAMINE MESYLATE PARTICLES USING A METERED DOSE INHALER
#583Dronabinol Treatment for Migraines
#584USE OF OSMOLYTES OBTAINED FROM EXTREMOPHILIC BACTERIA FOR THE PRODUCTION OF INHALABLE MEDICAMENTS FOR THE PROPHYLAXIS AND TREATMENT OF PULMONARY AND CARDIOVASCULAR DISEASES AND AN INHALATION DEVICE COMPRISING OSMOLYTE AS ACTIVE AGENT COMPONENT
#585COMBINATION THERAPY FOR COPD
#586AEROSOL FORMULATION FOR COPD
#587COMBINATION THERAPY FOR COPD
#588Process for improving crystallinity
#589AEROSOL FORMULATION FOR COPD
#590INHALABLE COMPOSITIONS HAVING ENHANCED BIOAVAILABILITY
#591COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS
#592COMBINATION OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#593COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
#594Compositions for pulmonary delivery of long-acting βadrenergic receptor agonists and associated methods and systems
#595Polysulfated glycosides and salts thereof
#596PRESSURISED METERED DOSE INHALERS (MDI)
#597Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
#598Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
#599Micelle encapsulation of therapeutic agents
#600Formoterol superfine formulation